Saitama, Japan

Kouji Tomuro

This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1988.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kouji Tomuro: Innovator in Pharmaceutical Formulations

Introduction

Kouji Tomuro is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release formulations. His innovative work has led to advancements that benefit patients requiring precise medication delivery.

Latest Patents

Kouji Tomuro holds a patent for a controlled-release multiple units pharmaceutical formulation. This formulation involves a granulation product that includes a release-controlling agent mixed with a physiologically active substance and units-forming substances. The granules produced from this process are designed to gradually release the active substance in the gastrointestinal tract, ensuring effective medication delivery.

Career Highlights

Throughout his career, Kouji Tomuro has been associated with Yamanouchi Pharmaceutical Company Ltd., where he has contributed to various research and development projects. His expertise in pharmaceutical formulations has positioned him as a key player in the industry.

Collaborations

Kouji has collaborated with esteemed colleagues, including Muneo Fukui and Shigeru Masuyama. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in pharmaceutical research.

Conclusion

Kouji Tomuro's work in controlled-release pharmaceutical formulations exemplifies the impact of innovation in healthcare. His contributions continue to enhance the effectiveness of medication delivery systems, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…